A Phase III Randomized, Double-Blind, Placebo Controlled Multicrentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutaded Advanced (FIGO Stage III-IV) Ovarian Cancer Following First Line Platinum Based Chemotherapy